BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6276738)

  • 1. Evaluation of 4CMB in the subcutaneous implant test.
    Longstaff E; Gaunt C
    Mutat Res; 1982; 100(1-4):395-7. PubMed ID: 6276738
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinogenicity bioassay of 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB) and benzyl chloride (BC) on mouse skin: interim (7 month) report.
    Ashby J; Gaunt C; Robinson M
    Mutat Res; 1982; 100(1-4):399-401. PubMed ID: 6276739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attempts to initiate skin tumours in mice in the 2-stage system using 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB), and benzyl chloride (BC). Report of the experiment at 10 months.
    Coombs MM
    Mutat Res; 1982; 100(1-4):403-5. PubMed ID: 6276740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The UKEMS genotoxicity trial. A summary of the assays for skin tumour induction in mice, the subcutaneous implant test and the sebaceous gland suppression test.
    Coombs MM
    Mutat Res; 1982; 100(1-4):407-9. PubMed ID: 6276741
    [No Abstract]   [Full Text] [Related]  

  • 5. Skin tumor promotion: a comparative study of several stocks and strains of mice.
    Reiners J; Davidson K; Nelson K; Mamrack M; Slaga T
    Basic Life Sci; 1983; 24():173-88. PubMed ID: 6305326
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the tumor-initiating activity of 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene in female SENCAR and CS-1 mice.
    DiGiovanni J; Slaga TJ; Boutwell RK
    Carcinogenesis; 1980 May; 1(5):381-9. PubMed ID: 6268318
    [No Abstract]   [Full Text] [Related]  

  • 7. Dermal carcinogenesis bioassays of diesel particulates and dichloromethane extract of diesel particulates in C3H mice.
    Depass LR; Chen KC; Peterson LG
    Dev Toxicol Environ Sci; 1982; 10():321-7. PubMed ID: 6176430
    [No Abstract]   [Full Text] [Related]  

  • 8. Skin carcinogenesis studies of emission extracts.
    Nesnow S; Evans C; Stead A; Creason J; Slaga TJ; Triplett LL
    Dev Toxicol Environ Sci; 1982; 10():295-320. PubMed ID: 6176428
    [No Abstract]   [Full Text] [Related]  

  • 9. The genetic toxicology of 4-chloromethylbiphenyl (4CMB), 4-hydroxymethylbiphenyl (4HMB) and benzyl chloride (BC) as assessed by the UKEMS genotoxicity trial (1981).
    Parry JM
    Mutat Res; 1982; 100(1-4):411-6. PubMed ID: 7035897
    [No Abstract]   [Full Text] [Related]  

  • 10. Accelerated development of benzo(alpha)pyrene-induced skin tumors in mice treated with pyran copolymer.
    Kripke ML; Borsos T
    J Natl Cancer Inst; 1974 Nov; 53(5):1409-10. PubMed ID: 4431058
    [No Abstract]   [Full Text] [Related]  

  • 11. Activity of 4CMB in the mouse-skin sebaceous-gland suppression test.
    Ashby J; Longstaff E
    Mutat Res; 1982; 100(1-4):391-3. PubMed ID: 7057779
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism and tumorigenicity of 7-, 8-, 9-, and 10-fluorobenzo(a)pyrenes.
    Buhler DR; Unlu F; Thakker DR; Slaga TJ; Newman MS; Levin W; Conney AH; Jerina DM
    Cancer Res; 1982 Nov; 42(11):4779-83. PubMed ID: 6290047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activation and inactivation mechanism of Benzo(a)pyrene (author's transl)].
    Nemoto N
    Tanpakushitsu Kakusan Koso; 1976 Dec; 21(12):957-71. PubMed ID: 827786
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental studies of the carcinogenicity and the retention of benzo(a)pyrene in application region after intratracheal and subcutaneous injection (author's transl)].
    Pott F; Tomingas R; Reiffer FJ
    Zentralbl Bakteriol Orig B; 1973 Oct; 158(2):97-108. PubMed ID: 4779177
    [No Abstract]   [Full Text] [Related]  

  • 15. FAILURE OF MONO-CHLOROACETONE TO INFLUENCE 3,4-BENZPYRENE MOUSE SKIN TUMORIGENESIS.
    ARGUS MF; ARCOS JC
    Experientia; 1963 Nov; 19():588-9. PubMed ID: 14101520
    [No Abstract]   [Full Text] [Related]  

  • 16. Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides.
    Slaga TJ; Bracken WJ; Gleason G; Levin W; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1979 Jan; 39(1):67-71. PubMed ID: 761200
    [No Abstract]   [Full Text] [Related]  

  • 17. Carcinogenicity of benzo-ring derivatives of benzo(a)pyrene on mouse skin.
    Levin W; Wood AW; Wislocki PG; Kapitulnik J; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1977 Sep; 37(9):3356-61. PubMed ID: 884679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity of benzo[a]pyrene 4,5-, 7,8-, and 9,10-oxides on mouse skin.
    Levin W; Wood AW; Yagi H; Dansette PM; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1976 Jan; 73(1):243-7. PubMed ID: 1061121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crude petroleum and selected fractions. Skin cancer bioassays.
    Lewis SC
    Prog Exp Tumor Res; 1983; 26():68-84. PubMed ID: 6302736
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo[a]pyrene and (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on mouse skin and in the newborn mouse.
    Chang RL; Huang MT; Wood AW; Wong CQ; Newmark HL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Carcinogenesis; 1985 Aug; 6(8):1127-33. PubMed ID: 3926336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.